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Introduction: Contrary to the general population, people with cystic ﬁbrosis (CF)
have, for primary nutritional recommendation, high-fat and high-calories diets. This
is mainly due to the fact that despite pancreatic enzymes supplementation (<80%),
intestinal malabsorption persists.
Objectives: Characterize lipid proﬁles, analyze the causes and potential complica-
tions of these abnormalities in CF patients and highlight a possible association with
abnormal glucose tolerance.
Subjects: 204 CF subjects and 15 control subjects were included in this study.
All subjects underwent an Oral Glucose Tolerance Test (OGTT) to determine
their glucose tolerance. Lipid proﬁles including total cholesterol, HDL, LDL and
triglycerides were measured at fasting state. An electronic scale was used to
determine body fat, lean mass and body mass index (BMI).
Results: Hypertriglyceridemia (HPTG) was found in 20 CF patients subsequently
matched with 20 non-HPTG CF patients. The matching criteria were gender, age,
pancreatic insufﬁciency, genotype and status of glucose tolerance. Comparing the
three groups (CF-HPTG, CF non-HPTG and non-CF) showed differences on the
secretion and insulin resistance. For a comparable glycemic status, CF-HPTG
patients had lower insulin sensitivity resulting in a higher secretion of insulin. BMI,
blood pressure, inﬂammation and lung capacity does not appear to differ between
groups. Women tend to be more frequently affected than men to HPTG.
Conclusion: HPTG appears to be an isolated phenomenon and do not seem to have
any complications encountered in the general population.
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Most patients with a severe clinical phenotype have low serum concentrations of
linoleic acid (LA) and its metabolite, arachidonic acid (AA) have been reported
high–low in different investigations. Warning has been raised that increase of LA in
patients with cystic ﬁbrosis (CF) would increase the AA concentration and thereby
increase the burden of inﬂammation. A general increase in eicosanoid metabolism
may support such hypothesis. However, in many studies an increase of LA has been
shown to down regulate the transformation to AA, giving a negative correlation
between LA and AA.
Objective: to investigate if similar or opposite relation was found between LA and
AA in CF compared to healthy individuals.
Methods: Plasma phospholipid fatty acid concentration was determined with
capillary gas-chromatography in 168 patients with CF aged one to 54 years and
compared to 97 healthy children.
There were inverse correlations between LA and AA in both healthy individuals
and in patients with CF, being r = −0.490, p< 0.0001 and r = −0.278, p = 0.0003,
respectively. The difference was mainly due to a wider variation in CF, with
generally lower AA (mean (SD) 8.18 (1.46) %, range 5.26–13.04) than in healthy
controls (mean (SD) 8.68 (1.24) %, range 5.93–11.57) (p = 0.002).
Conclusion: There is no indication that high LA would increase AA in patients
with CF. However, intake of meat or other products with high AA, might increase
AA in CF patients as well as in healthy individuals.
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Aim: To compare behavioral and nutritional intervention (BEH) with a usual
care control condition (CTL) for cystic ﬁbrosis (CF) children with pancreatic
insufﬁciency. This trial was designed to: (a) compare BEH with CTL over 8 weeks,
(b) evaluate the maintenance of BEH at 3- and 6-month follow-up.
Methods: Twenty-four children with CF (aged 8 months to 18 years) that were
treated according to the CF Consensus Guidelines for nutritional care (CTL),
were reviewed by a dietician and were assigned to BEH. BEH included nutrition
counseling to increase energy intake and child behavioral management training.
Children were reviewed 2, 3 and 6 months after initial assessment.
Results: BEH led to greater increases in energy intake post-treatment than CTL as
measured by calories per day (842 kcal/day vs _131 kcal/day change). At 3-month
follow-up, energy intake increased signiﬁcantly (765 kcal/day vs 475 kcal/day).
Weight gain and BMI z score increased signiﬁcantly (mean, 1.39 vs. 0.85 kg and
0.39 vs. 0.14, respectively.
Conclusions: These preliminary results show that a behavioral − nutritional educa-
tion intervention was more effective than a usual control education among children
with CF.
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Background: Patients with cystic ﬁbrosis (CF) are traditionally thought to need
120–150% of the energy intake of their equivocal counterparts without CF. In more
recent years clinicians have begun to question whether an increased need for energy
really exists particularly when a child with CF is well and asymptomatic.
Objectives:
1. To establish whether children with CF who are asymptomatic consume a higher
energy intake than children without CF by comparing their actual energy intakes
with the Estimated Average Energy Requirement (EAR).
2. To assess PERT adequacy.
3. To assess nutritional status in terms of growth and adequacy of weight gain.
Patients and Methods: 32 children with pancreatic-insufﬁcient (PI) CF: 21 boys
(age range 3–16.6 yrs) and 11 girls (age range 1–16.9 yrs) completed a 3 day food
diary which was computer analysed. Weight, height and BMI were plotted and
% weight for height calculated. PERT dosage was assessed by lipase dosage and
steathorrea.
Results: The average lipase dose was 10,900 iu/kg/day for the boys and
9,400 iu/kg/day for girls: none of the children reported symptoms associated with
steathorrea. All except one child (5%) had an acceptable nutritional status. All
children were growing along appropriate centiles. The average intake for energy
for each age group did not appear to be signiﬁcantly different to the EAR with the
exception of girls aged 11−14 years whose average energy intake was 20% greater
than the EAR
Conclusions: It would seem that when well, asymptomatic children with CF
with a good nutritional status, appropriately dosed PERT and regular input from
an experienced dietitian need no more energy than their age and sex matched
counterparts without CF.
